Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Harper

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Seminars in Oncology|June 26, 2002
Current clinical practices for ovarian cancersPeter Harper
Science Progress|July 26, 2017
Decomposition for decarbonisation: evaluation of decarbonisation programmesPeter Harper
Targeted Oncology|October 31, 2009
Targets, targeted targets and molecular imaging: new potential treatments, new treatments and new ways of assessing treatmentsPeter Harper
BMJ (Clinical Research Ed.)|March 14, 1992
Genetics and public healthPeter Harper
Seminars in Oncology|August 15, 2003
Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancerPeter Harper
Lung Cancer (Amsterdam, Netherlands)|November 15, 2002
Non-platinum gemcitabine combinations in non-small cell lung cancerGavin Marx, Peter Harper
Oncology|October 26, 2005
Anaemia of cancer: impact on patient fatigue and long-term outcomePeter Harper, Timothy Littlewood
Seminars in Oncology|June 26, 2002
The optimal hemoglobin level in the cancer patientMario Dicato, Peter Harper
American Journal of Clinical Oncology|October 24, 2002
Palliative treatment: what's the point?Alistair Ring, Peter Harper
Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancerLesley J Fallowfield, Peter Harper
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Seminars in Oncology|June 26, 2002
Current clinical practices for ovarian cancersPeter Harper
Science Progress|July 26, 2017
Decomposition for decarbonisation: evaluation of decarbonisation programmesPeter Harper
Targeted Oncology|October 31, 2009
Targets, targeted targets and molecular imaging: new potential treatments, new treatments and new ways of assessing treatmentsPeter Harper
BMJ (Clinical Research Ed.)|March 14, 1992
Genetics and public healthPeter Harper
Seminars in Oncology|August 15, 2003
Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancerPeter Harper
Lung Cancer (Amsterdam, Netherlands)|November 15, 2002
Non-platinum gemcitabine combinations in non-small cell lung cancerGavin Marx, Peter Harper
Oncology|October 26, 2005
Anaemia of cancer: impact on patient fatigue and long-term outcomePeter Harper, Timothy Littlewood
Seminars in Oncology|June 26, 2002
The optimal hemoglobin level in the cancer patientMario Dicato, Peter Harper
American Journal of Clinical Oncology|October 24, 2002
Palliative treatment: what's the point?Alistair Ring, Peter Harper
Lung Cancer (Amsterdam, Netherlands)|May 17, 2005
Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancerLesley J Fallowfield, Peter Harper
Pageof 5